The basis and value of currently used immunomodulatory therapies in recurrent miscarriage

Journal of Reproductive Immunology

Volumn 93, Issue 1, 2012, Pages 41-51

  Bansal, A S ^a   Bajardeen, B ^a   Thum, M Y ^b  

^a ST HELIER HOSPITAL   (United Kingdom)

^b LISTER HOSPITAL   (United Kingdom)

Author keywords

NK cells; Recurrent miscarriage; T cells; Treatment

Indexed keywords

ACETYLSALICYLIC ACID; ADALIMUMAB; ANTICOAGULANT AGENT; CALCITRIOL; DYDROGESTERONE; ETANERCEPT; FOLIC ACID; FORMOTEROL; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; INFLIXIMAB; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 6; INTRALIPID; LEVOTHYROXINE; LOW MOLECULAR WEIGHT HEPARIN; PREDNISOLONE; PREDNISONE; PROGESTERONE; SALBUTAMOL; SALMETEROL; STEROID; THYROXINE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; VASCULAR CELL ADHESION MOLECULE 1; VITAMIN D;

ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNITY; BIRTH RATE; CD3+ T LYMPHOCYTE; CD4 CD8 RATIO; CELL ADHESION; CELL MEDIATED CYTOTOXICITY; CONGENITAL HEART MALFORMATION; CORTICOSTEROID THERAPY; CYTOKINE RELEASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG USE; EMBRYO TRANSFER; ENDOMETRIUM; ENDOTOXEMIA; ENTERITIS; FERTILIZATION IN VITRO; FIRST TRIMESTER PREGNANCY; HAEMOPHILUS INFLUENZAE TYPE B; HORMONE SUBSTITUTION; HUMAN; IDIOPATHIC DISEASE; IMMUNOTHERAPY; LOW DRUG DOSE; LYMPHOCYTE PROLIFERATION; MYCOPLASMOSIS; NATURAL KILLER CELL; NONHUMAN; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREMATURITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSYCHOSIS; RECURRENT DISEASE; RECURRENT MISCARRIAGE; REGULATORY T LYMPHOCYTE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SPONTANEOUS ABORTION; STREPTOCOCCUS PNEUMONIAE; SYNCYTIOTROPHOBLAST; T LYMPHOCYTE ACTIVATION; TH1 TH2 BALANCE; TH17 CELL; THIRD TRIMESTER PREGNANCY; TROPHOBLAST; UNSPECIFIED SIDE EFFECT; UPREGULATION; VAGINITIS; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ABORTION, HABITUAL; ANIMALS; CYTOTOXICITY, IMMUNOLOGIC; ENDOMETRIUM; FEMALE; HUMANS; IMMUNOMODULATION; IMMUNOTHERAPY; KILLER CELLS, NATURAL; PREGNANCY; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

EID: 84856402885     PISSN: 01650378     EISSN: 18727603     Source Type: Journal    
DOI: 10.1016/j.jri.2011.10.002     Document Type: Review

References (111)

1. Abrahams V.M. Mechanisms of antiphospholipid antibody-associated pregnancy complications. Thromb. Res. 2009, 124(5):521-525.
2. Anthony R.M., Ravetch J.V. A novel role for the IgG Fc glycan: the anti-inflammatory activity of sialylated IgG Fcs. J. Clin. Immunol. 2010, 30(Suppl. 1):S9-S14.
3. Araujo L.M., Chauvineau A., Zhu R., Diem S., Bourgeois E.A., Levescot A., Huerre M., Gombert J.M., Bayry J., Daëron M., Bruhns P., Kaveri S.V., Herbelin A. Cutting edge: intravenous Ig inhibits invariant NKT cell-mediated allergic airway inflammation through FcγRIIIA-dependent mechanisms. J. Immunol. 2011, 186(6):3289-3293.
4. 3 and cytokine plasma profiles under different postoperative parenteral nutrition regimens. Nutrition 1996, 12(2):89-92.
5. Arnson Y., Shoenfeld Y., Amital H. Intravenous immunoglobulin therapy for autoimmune diseases. Autoimmunity 2009, 42(6):553-560.
6. Ata B., Tan S.L., Shehata F., Holzer H., Buckett W. A systematic review of intravenous immunoglobulin for treatment of unexplained recurrent miscarriage. Fertil. Steril. 2011, 95(3). 1080-5.e1-1080-5.e2.
7. Ballow M. The IgG molecule as a biological immune response modifier: mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders. J. Allergy Clin. Immunol. 2011, 127(2):315-323.
8. Bansal A.S. Joining the immunological dots in recurrent miscarriage. Am. J. Reprod. Immunol. 2010, 64:307-315.
9. Bansal A.S., Bajardeen B., Shehata H., Thum M.Y. Recurrent miscarriage and autoimmunity. Expert Rev. Clin. Immunol. 2011, 7(1):37-44.
10. Bohn A.B., Nederby L., Harbo T., Skovbo A., Vorup-Jensen T., Krog J., Jakobsen J., Hokland M.E. The effect of IgG levels on the number of natural killer cells and their Fc receptors in chronic inflammatory demyelinating polyradiculoneuropathy. Eur. J. Neurol. 2011, 18(6):919-924.
11. Bosnar M., Bosnjak B., Cuzic S., Hrvacic B., Marjanovic N., Glojnaric I., Culic O., Parnham M.J., Haber V.E. Azithromycin and clarithromycin inhibit lipopolysaccharide-induced murine pulmonary neutrophilia mainly through effects on macrophage-derived granulocyte-macrophage colony-stimulating factor and interleukin-1beta. J. Pharmacol. Exp. Ther. 2009, 331(1):104-113.
12. Bruce D., Yu S., Ooi J.H., Cantorna M.T. Converging pathways lead to overproduction of IL-17 in the absence of vitamin D signaling. Int. Immunol. 2011, 23(8):519-528.
13. Bubanovic I. 1Alpha, 25-dihydroxy-vitamin-D3 as new immunotherapy in treatment of recurrent spontaneous abortion. Med. Hypotheses 2004, 63(2):250-253.
14. Bulmer J.N., Williams P.J., Lash G.E. Immune cells in the placental bed. Int. J. Dev. Biol. 2010, 54:281-294.
15. Carp H.J., Toder V., Gazit E., Ahiron R., Torchinski A., Mashiach S., Shoenfeld Y. Further experience with intravenous immunoglobulin in women with recurrent miscarriage and a poor prognosis. Am. J. Reprod. Immunol. 2001, 46(4):268-273.
16. Clark D.A., Banwatt D., Chaouat G. Effect of prostaglandin synthesis inhibitors on spontaneous and endotoxin-induced abortion in mice. J. Reprod. Immunol. 1993, 24(1):29-44.
17. Cowchock F.S., Reece E.A., Balaban D., Branch D.W., Plouffe L. Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am. J. Obstet. Gynecol. 1992, 166(5):1318-1323.
18. Dao Nguyen X., Robinson D.S. Fluticasone propionate increases CD4CD25 T regulatory cell suppression of allergen-stimulated CD4CD25 T cells by an IL-10-dependent mechanism. J. Allergy Clin. Immunol. 2004, 114(2):296-301.
19. Daya S., Gunby J., Porter F., Scott J., Clark D.A. Critical analysis of intravenous immunoglobulin therapy for recurrent miscarriage. Hum. Reprod. Update 1999, 5(5):475-482.
20. Dendrinos S., Sakkas E., Makrakis E. Low-molecular-weight heparin versus intravenous immunoglobulin for recurrent abortion associated with antiphospholipid antibody syndrome. Int. J. Gynaecol. Obstet. 2009, 104(3):223-225.
21. Dodel R., Neff F., Noelker C., Pul R., Du Y., Bacher M., Oertel W. Intravenous immunoglobulins as a treatment for Alzheimer's disease: rationale and current evidence. Drugs 2010, 70(5):513-528.
22. Donders G.G., Van Calsteren K., Bellen G., Reybrouck R., Van den Bosch T., Riphagen I., Van Lierde S. Predictive value for preterm birth of abnormal vaginal flora, bacterial vaginosis and aerobic vaginitis during the first trimester of pregnancy. BJOG 2009, 116(10):1315-1324.
23. Empson M., Lassere M., Craig J., Scott J. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst. Rev. 2005, (2):CD002859.
24. Equils O., Lu D., Gatter M., Witkin S.S., Bertolotto C., Arditi M., McGregor J.A., Simmons C.F., Hobel C.J. Chlamydia heat shock protein 60 induces trophoblast apoptosis through TLR4. J. Immunol. 2006, 177(2):1257-1263.
25. Evans K.N., Nguyen L., Chan J., Innes B.A., Bulmer J.N., Kilby M.D., Hewison M. Effects of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on cytokine production by human decidual cells. Biol. Reprod. 2006, 75(6):816-822.
26. Finan R.R., Al-Irhayim Z., Mustafa F.E., Al-Zaman I., Mohammed F.A., Al-Khateeb G.M., Madan S., Issa A.A., Almawi W.Y. Tumor necrosis factor-alpha polymorphisms in women with idiopathic recurrent miscarriage. J. Reprod. Immunol. 2010, 84(2):186-192.
27. Furukawa K., Yamamori H., Takagi K., Hayashi N., Suzuki R., Nakajima N., Tashiro T. Influences of soybean oil emulsion on stress response and cell-mediated immune function in moderately or severely stressed patients. Nutrition 2002, 18(3):235-240.
28. Gleicher N., Vidali A., Barad D.H. Successful treatment of unresponsive thin endometrium. Fertil. Steril. 2011, 95(6). 2123.e13-2123.e17.
29. Granato D., Blum S., Rössle C., Le Boucher J., Malnoë A., Dutot G. Effects of parenteral lipid emulsions with different fatty acid composition on immune cell functions in vitro. JPEN J. Parenter. Enteral Nutr. 2000, 24(2):113-118.
30. Hartung H.P., Mouthon L., Ahmed R., Jordan S., Laupland K.B., Jolles S. Clinical applications of intravenous immunoglobulins (IVIg) - beyond immunodeficiencies and neurology. Clin. Exp. Immunol. 2009, 158(Suppl. 1):23-33.
31. Hasegawa I., Takakuwa K., Goto S., Yamada K., Sekizuka N., Kanazawa K., Tanaka K. Effectiveness of prednisolone/aspirin therapy for recurrent aborters with antiphospholipid antibody. Hum. Reprod. 1992, 7(2):203-207.
32. + natural killer cells and improvement of pregnancy outcome in IVF/ICSI failure after additional IVIG-treatment. Am. J. Reprod. Immunol. 2010, 63:263-265.
33. Hermoso M.A., Cidlowski J.A. Putting the brake on inflammatory responses: the role of glucocorticoids. IUBMB Life 2003, 55(9):497-504.
34. Hung C.H., Chu Y.T., Hua Y.M., Hsu S.H., Lin C.S., Chang H.C., Lee M.S., Jong Y.J. Effects of formoterol and salmeterol on the production of Th1- and Th2-related chemokines by monocytes and bronchial epithelial cells. Eur. Respir. J. 2008, 31(6):1313-1321.
35. Hutton B., Sharma R., Fergusson D., Tinmouth A., Hebert P., Jamieson J., Walker M. Use of intravenous immunoglobulin for treatment of recurrent miscarriage: a systematic review. BJOG 2007, 114(2):134-142.
36. Jerzak M., Rechberger T., Górski A. Intravenous immunoglobulin therapy influences T cell adhesion to extracellular matrix in women with a history of recurrent spontaneous abortions. Am. J. Reprod. Immunol. 2000, 44(6):336-341.
37. Jordan S.C., Toyoda M., Vo A.A. Regulation of immunity and inflammation by intravenous immunoglobulin: relevance to solid organ transplantation. Expert Rev. Clin. Immunol. 2011, 7(3):341-348.
38. Kalu E., Bhaskaran S., Thum M.Y., Vishwanatha R., Croucher C., Sherriff E., Ford B., Bansal A.S. Serial estimation of Th1:th2 cytokines profile in women undergoing in-vitro fertilization-embryo transfer. Am. J. Reprod. Immunol. 2008, 59(3.):206-211.
39. Kim N.Y., Cho H.J., Kim H.Y., Yang K.M., Ahn H.K., Thornton S., Park J.C., Beaman K., Gilman-Sachs A., Kwak-Kim J. Thyroid autoimmunity and its association with cellular and humoral immunity in women with reproductive failures. Am. J. Reprod. Immunol. 2011, 65(1):78-87.
40. Kiprov D.D., Nachtigall R.D., Weaver R.C., Jacobson A., Main E.K., Garovoy M.R. The use of intravenous immunoglobulin in recurrent pregnancy loss associated with combined alloimmune and autoimmune abnormalities. Am. J. Reprod. Immunol. 1996, 36(4):228-234.
41. Kotlan B., Padanyi A., Batorfi J., Fulop V., Szigetvari I., Rajczy K., Penzes M., Gyodi E., Reti M., Petranyi G. Alloimmune and autoimmune background in recurrent pregnancy loss - successful immunotherapy by intravenous immunoglobulin. Am. J. Reprod. Immunol. 2006, 55(5):331-340.
42. Krogh-Madsen R., Plomgaard P., Akerstrom T., Møller K., Schmitz O., Pedersen B.K. Effect of short-term intralipid infusion on the immune response during low-dose endotoxemia in humans. Am. J. Physiol. Endocrinol. Metab. 2008, 294(2):E371-E379.
43. Lash G.E., Robson S.C., Bulmer J.N. Review: functional role of uterine natural killer (uNK) cells in human early pregnancy decidua. Placenta 2010, 31(Suppl.):S87-S92.
44. Laskin C.A., Bombardier C., Hannah M.E., Mandel F.P., Ritchie J.W., Farewell V., Farine D., Spitzer K., Fielding L., Soloninka C.A., Yeung M. Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. N. Engl. J. Med. 1997, 337(3):148-153.
45. Laskin C.A., Spitzer K.A., Clark C.A., Crowther M.R., Ginsberg J.S., Hawker G.A., Kingdom J.C., Barrett J., Gent M. Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA trial. J. Rheumatol. 2009, 36(2):279-287.
46. Lea R.G., Tulppala M., Critchley H.O. Deficient syncytiotrophoblast tumour necrosis factor-alpha characterizes failing first trimester pregnancies in a subgroup of recurrent miscarriage patients. Hum. Reprod. 1997, 12(6):1313-1320.
47. Lédée N., Frydman R., Osipova A., Taieb J., Gallot V., Lombardelli L., Logiodice F., Petitbarat M., Fanchin R., Chaouat G., Achour-Frydman N., Piccinni M.P. Levels of follicular G-CSF and interleukin-15 appear as noninvasive biomarkers of subsequent successful birth in modified natural in vitro fertilization/intracytoplasmic sperm injection cycles. Fertil. Steril. 2011, 95(1):94-98.
48. Liang B., Wang S., Ye Y.J., Yang X.D., Wang Y.L., Qu J., Xie Q.W., Yin M.J. Impact of postoperative omega-3 fatty acid-supplemented parenteral nutrition on clinical outcomes and immunomodulations in colorectal cancer patients. World J. Gastroenterol. 2008, 14(15):2434-2439.
49. Linhares I.M., Witkin S.S. Immunopathogenic consequences of Chlamydia trachomatis 60kDa heat shock protein expression in the female reproductive tract. Cell Stress Chaperones 2010, 15(5):467-473.
50. Maddur M.S., Othy S., Hegde P., Vani J., Lacroix-Desmazes S., Bayry J., Kaveri S.V. Immunomodulation by intravenous immunoglobulin: role of regulatory T cells. J. Clin. Immunol. 2010, 30(Suppl. 1):S4-S8.
51. Maddur M.S., Vani J., Hegde P., Lacroix-Desmazes S., Kaveri S.V., Bayry J. Inhibition of differentiation, amplification, and function of human TH17 cells by intravenous immunoglobulin. J. Allergy Clin. Immunol. 2011, 127(3). 823-30.e1-7.
52. Magga J., Puli L., Pihlaja R., Kanninen K., Neulamaa S., Malm T., Härtig W., Grosche J., Goldsteins G., Tanila H., Koistinaho J., Koistinaho M. Human intravenous immunoglobulin provides protection against Aβ toxicity by multiple mechanisms in a mouse model of Alzheimer's disease. J. Neuroinflammation 2010, 7:90.
53. Mark P.J., Waddell B.J. P-glycoprotein restricts access of cortisol and dexamethasone to the glucocorticoid receptor in placental BeWo cells. Endocrinology 2006, 147(11):5147-5152.
54. Medica I., Ostojic S., Pereza N., Kastrin A., Peterlin B. Association between genetic polymorphisms in cytokine genes and recurrent miscarriage - a meta-analysis. Reprod. Biomed. Online 2009, 19(3):406-414.
55. Nakashima A., Ito M., Yoneda S., Shiozaki A., Hidaka T., Saito S. Circulating and decidual Th17 cell levels in healthy pregnancy. Am. J. Reprod. Immunol. 2010, 63(2):104-109.
56. Nisoli E., Carruba M.O., Tonello C., Macor C., Federspil G., Vettor R. Induction of fatty acid translocase/CD36, peroxisome proliferator-activated receptor-gamma2, leptin, uncoupling proteins 2 and 3, and tumor necrosis factor-alpha gene expression in human subcutaneous fat by lipid infusion. Diabetes 2000, 49(3):319-324.
57. Novac N., Baus D., Dostert A., Heinzel T. Competition between glucocorticoid receptor and NFkappaB for control of the human FasL promoter. FASEB J. 2006, 20(8):1074-1081.
58. Ogasawara M., Aoki K. Successful uterine steroid therapy in a case with a history of ten miscarriages. Am. J. Reprod. Immunol. 2000, 44(4):253-255.
59. Okano M. Mechanisms and clinical implications of glucocorticosteroids in the treatment of allergic rhinitis. Clin. Exp. Immunol. 2009, 158(2):164-173.
60. Otun H.A., Lash G.E., Innes B.A., Bulmer J.N., Naruse K., Hannon T., Searle R.F., Robson S.C. Effect of tumour necrosis factor-α in combination with interferon-γ on first trimester extravillous trophoblast invasion. J. Reprod. Immunol. 2011, 88(1):1-11.
61. Palmirotta R., La Farina F., Ferroni P., Ludovici G., Nigro C., Savonarola A., Raparelli V., Riondino S., Rampini M.R., Guadagni F., Basili S. TNFA gene promoter polymorphisms and susceptibility to recurrent pregnancy loss in Italian women. Reprod. Sci. 2010, 17(7):659-666.
62. Patel S., Puranik R., Nakhla S., Lundman P., Stocker R., Wang X.S., Lambert G., Rye K.A., Barter P.J., Nicholls S.J., Celermajer D.S. Acute hypertriglyceridaemia in humans increases the triglyceride content and decreases the anti-inflammatory capacity of high density lipoproteins. Atherosclerosis 2009, 204(2):424-428.
63. Peek E.J., Richards D.F., Faith A., Lavender P., Lee T.H., Corrigan C.J., Hawrylowicz C.M. Interleukin-10-secreting " regulatory" T cells induced by glucocorticoids and beta2-agonists. Am. J. Respir. Cell Mol. Biol. 2005, 33(1):105-111.
64. Perricone R., De Carolis C., Giacomelli R., Guarino M.D., De Sanctis G., Fontana L. GM-CSF and pregnancy: evidence of significantly reduced blood concentrations in unexplained recurrent abortion efficiently reverted by intravenous immunoglobulin treatment. Am. J. Reprod. Immunol. 2003, 50(3):232-237.
65. Perricone R., Di Muzio G., Perricone C., Giacomelli R., De Nardo D., Fontana L., De Carolis C. High levels of peripheral blood NK cells in women suffering from recurrent spontaneous abortion are reverted from high-dose intravenous immunoglobulins. Am. J. Reprod. Immunol. 2006, 55(3):232-239.
66. Prietl B., Pilz S., Wolf M., Tomaschitz A., Obermayer-Pietsch B., Graninger W., Pieber T.R. Vitamin D supplementation and regulatory T cells in apparently healthy subjects: vitamin D treatment for autoimmune diseases?. Isr. Med. Assoc. J. 2010, 12(3):136-139.
67. Quenby S., Farquharson R., Young M., Vince G. Successful pregnancy outcome following 19 consecutive miscarriages: case report. Hum. Reprod. 2003, 18(12):2562-2564.
68. Quenby S., Kalumbi C., Bates M., Farquharson R., Vince G. Prednisolone reduces preconceptual endometrial natural killer cells in women with recurrent miscarriage. Fertil. Steril. 2005, 84(4):980-984.
69. Quinn P.A., Shewchuk A.B., Shuber J., Lie K.I., Ryan E., Chipman M.L., Nocilla D.M. Efficacy of antibiotic therapy in preventing spontaneous pregnancy loss among couples colonized with genital mycoplasmas. Am. J. Obstet. Gynecol. 1983, 145(2):239-244.
70. Raghupathy R., Kalinka J. Cytokine imbalance in pregnancy complications and its modulation. Front. Biosci. 2008, 13:985-994.
71. Raghupathy R., Al Mutawa E., Makhseed M., Azizieh F., Szekeres-Bartho J. Modulation of cytokine production by dydrogesterone in lymphocytes from women with recurrent miscarriage. BJOG 2005, 112(8):1096-1101.
72. Ramsey-Goldman R., Schilling E. Immunosuppressive drug use during pregnancy. Rheum. Dis. Clin. North Am. 1997, 23(1):149-167.
73. Read T.E., Grunfeld C., Kumwenda Z.L., Calhoun M.C., Kane J.P., Feingold K.R., Rapp J.H. Triglyceride-rich lipoproteins prevent septic death in rats. J. Exp. Med. 1995, 182(1):267-272.
74. Revelli A., Casano S., Piane L.D., Grassi G., Gennarelli G., Guidetti D., Massobrio M. A retrospective study on IVF outcome in euthyroid patients with anti-thyroid antibodies: effects of levothyroxine, acetyl-salicylic acid and prednisolone adjuvant treatments. Reprod. Biol. Endocrinol. 2009, 7:137.
75. Reznikoff-Etievant M.F., Cayol V., Zou G.M., Abuaf N., Robert A., Johanet C., Milliez J. Habitual abortions in 678 healthy patients: investigation and prevention. Hum. Reprod. 1999, 14(8):2106-2109.
76. Roussev R.G., Ng S.C., Coulam C.B. Natural killer cell functional activity suppression by intravenous immunoglobulin, intralipid and soluble human leukocyte antigen-G. Am. J. Reprod. Immunol. 2007, 57(4):262-269.
77. Roussev R.G., Acacio B., Ng S.C., Coulam C.B. Duration of intralipid's suppressive effect on NK cell's functional activity. Am. J. Reprod. Immunol. 2008, 60(3):258-263.
78. Salo M., Pirttikangas C.O., Pulkki K. Effects of propofol emulsion and thiopentone on T helper cell type-1/type-2 balance in vitro. Anaesthesia 1997, 52(4):341-344.
79. Sapir T., Shoenfeld Y. Uncovering the hidden potential of intravenous immunoglobulin as an anticancer therapy. Clin. Rev. Allergy Immunol. 2005, 29(3):307-310.
80. Scarpellini F., Sbracia M. Use of granulocyte colony-stimulating factor for the treatment of unexplained recurrent miscarriage: a randomised controlled trial. Hum. Reprod. 2009, 24(11):2703-2708.
81. Scott J.R. Immunotherapy for recurrent miscarriage. Cochrane Database Syst. Rev. 2003, (1). CD000112.
82. Shimada S., Takeda M., Nishihira J., Kaneuchi M., Sakuragi N., Minakami H., Yamada H. A high dose of intravenous immunoglobulin increases CD94 expression on natural killer cells in women with recurrent spontaneous abortion. Am. J. Reprod. Immunol. 2009, 62(5):301-307.
83. Sirota L., Straussberg R., Notti I., Bessler H. Effect of lipid emulsion on IL-2 production by mononuclear cells of newborn infants and adults. Acta Paediatr. 1997, 86(4):410-413.
84. Smolders J., Thewissen M., Peelen E., Menheere P., Tervaert J.W., Damoiseaux J., Hupperts R. Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis. PLoS One 2009, 4(8):e6635.
85. Smolders J., Peelen E., Thewissen M., Cohen Tervaert J.W., Menheere P., Hupperts R., Damoiseaux J. Safety and T cell modulating effects of high dose vitamin D3 supplementation in multiple sclerosis. PLoS One 2010, 5(12):e15235.
86. Srivastava P., Jha R., Bas S., Salhan S., Mittal A. In infertile women, cells from Chlamydia trachomatis infected sites release higher levels of interferon-gamma, interleukin-10 and tumor necrosis factor-alpha upon heat-shock-protein stimulation than fertile women. Reprod. Biol. Endocrinol. 2008, 6:20.
87. Stephenson M.D., Kutteh W.H., Purkiss S., Librach C., Schultz P., Houlihan E., Liao C. Intravenous immunoglobulin and idiopathic secondary recurrent miscarriage: a multicentered randomized placebo-controlled trial. Hum. Reprod. 2010, 25(9):2203-2209.
88. Stricker R.B., Winger E.E. Update on treatment of immunologic abortion with low-dose intravenous immunoglobulin. Am. J. Reprod. Immunol. 2005, 54(6):390-396.
89. Szereday L., Späth P., Szekeres-Bartho J. Natural killer cell activity and cytokine production after in vitro immunoglobulin treatment of lymphocytes derived from pregnant women with or without risk for spontaneous abortion. Am. J. Reprod. Immunol. 1999, 42(5):282-287.
90. Tang A.W., Alfirevic Z., Quenby S. Natural killer cells and pregnancy outcomes in women with recurrent miscarriage and infertility: a systematic review. Hum. Reprod. 2011, 26(8):1971-1980.
91. Tempfer C.B., Kurz C., Bentz E.K., Unfried G., Walch K., Czizek U., Huber J.C. A combination treatment of prednisone, aspirin, folate, and progesterone in women with idiopathic recurrent miscarriage: a matched-pair study. Fertil. Steril. 2006, 86(1):145-148.
92. Thum M.Y., Bhaskaran S., Abdalla H.I., Ford B., Sumar N., Bansal A. Prednisolone suppresses NK cell cytotoxicity in vitro in women with a history of infertility and elevated NK cell cytotoxicity. Am. J. Reprod. Immunol. 2008, 59(3):259-265.
93. Toder V., Fein A., Carp H., Torchinsky A. TNF-alpha in pregnancy loss and embryo maldevelopment: a mediator of detrimental stimuli or a protector of the fetoplacental unit?. J. Assist. Reprod. Genet. 2003, 20(2):73-81.
94. van den Heuvel M.J., Peralta C.G., Hatta K., Han V.K., Clark D.A. Decline in number of elevated blood CD3(+) CD56(+) NKT cells in response to intravenous immunoglobulin treatment correlates with successful pregnancy. Am. J. Reprod. Immunol. 2007, 58(5):447-459.
95. van der Poll T., Braxton C.C., Coyle S.M., Boermeester M.A., Wang J.C., Jansen P.M., Montegut W.J., Calvano S.E., Hack C.E., Lowry S.F. Effect of hypertriglyceridemia on endotoxin responsiveness in humans. Infect. Immun. 1995, 63(9):3396-3400.
96. Vaquero E., Lazzarin N., De Carolis C., Valensise H., Moretti C., Ramanini C. Mild thyroid abnormalities and recurrent spontaneous abortion: diagnostic and therapeutical approach. Am. J. Reprod. Immunol. 2000, 43(4):204-208.
97. Vassiliadou N., Searle R.F., Bulmer J.N. Elevated expression of activation molecules by decidual lymphocytes in women suffering spontaneous early pregnancy loss. Hum. Reprod. 1999, 14(5):1194-1200.
98. Vazquez W.D., Arya G., Garcia V.F. Long-chain predominant lipid emulsions inhibit in vitro macrophage tumor necrosis factor production. JPEN J. Parenter. Enteral Nutr. 1994, 18(1):35-39.
99. Wang W.J., Hao C.F., Yi-Lin, Yin G.J., Bao S.H., Qiu L.H., Lin Q.D. Increased prevalence of T helper 17 (Th17) cells in peripheral blood and decidua in unexplained recurrent spontaneous abortion patients. J. Reprod. Immunol. 2010, 84(2):164-170.
100. Whitcomb B.W., Schisterman E.F., Luo X., Chegini N. Maternal serum granulocyte colony-stimulating factor levels and spontaneous preterm birth. J. Womens Health (Larchmt) 2009, 18(1):73-78.
101. Winger E.E., Reed J.L. Treatment with tumor necrosis factor inhibitors and intravenous immunoglobulin improves live birth rates in women with recurrent spontaneous abortion. Am. J. Reprod. Immunol. 2008, 60(1):8-16.
102. Winger E.E., Reed J.L., Ashoush S., Ahuja S., El-Toukhy T., Taranissi M. Treatment with adalimumab (Humira) and intravenous immunoglobulin improves pregnancy rates in women undergoing IVF. Am. J. Reprod. Immunol. 2009, 61(2):113-120.
103. Winger E.E., Reed J.L., Ashoush S., El-Toukhy T., Ahuja S., Taranissi M. Elevated preconception CD56(+) 16(+) and/or Th1:Th2 levels predict benefit from IVIG therapy in subfertile women undergoing IVF. Am. J. Reprod. Immunol. 2011, 66(5):394-403.
104. ®) to treat immunologic-based infertility in IVF patients. Am. J. Reprod. Immunol. 2011, 66(3):237-241.
105. Wolkowitz O.M., Reus V.I., Canick J., Levin B., Lupien S. Glucocorticoid medication, memory and steroid psychosis in medical illness. Ann. N.Y. Acad. Sci. 1997, 823:81-96.
106. Würfel W. Approaches to a better implantation. J. Assist. Reprod. Genet. 2000, 17:473.
107. Würfel W., Santjohanser C., Hirv K., Bühl M., Meri O., Laubert I., von Hertwig I., Fiedler K., Krüsmann J., Krüsmann G. High pregnancy rates with administration of granulocyte colony-stimulating factor in ART-patients with repetitive implantation failure and lacking killer-cell immunglobulin-like receptors. Hum. Reprod. 2010, 25(8):2151-2152.
108. Yamada H., Morikawa M., Furuta I., Kato E.H., Shimada S., Iwabuchi K., Minakami H. Intravenous immunoglobulin treatment in women with recurrent abortions: increased cytokine levels and reduced Th1/Th2 lymphocyte ratio in peripheral blood. Am. J. Reprod. Immunol. 2003, 49(2):84-89.
109. Yang K.M., Ntrivalas E., Cho H.J., Kim N.Y., Beaman K., Gilman-Sachs A., Kwak-Kim J. Women with multiple implantation failures and recurrent pregnancy losses have increased peripheral blood T cell activation. Am. J. Reprod. Immunol. 2010, 63(5):370-378.
110. Zelinkova Z., de Haar C., de Ridder L., Pierik M.J., Kuipers E.J., Peppelenbosch M.P., van der Woude C.J. High intra-uterine exposure to infliximab following maternal anti-TNF treatment during pregnancy. Aliment. Pharmacol. Ther. 2011, 33(9):1053-1058.
111. Zhang J., Chen Z., Smith G.N., Croy B.A. Natural killer cell-triggered vascular transformation: maternal care before birth?. Cell. Mol. Immunol. 2011, 8(1):1-11.